Challenging the Value of Minimal Residual Disease in Predicting Outcome of Patients With Chronic Lymphocytic Leukemia

J Clin Oncol. 2023 Jul 20;41(21):3676-3678. doi: 10.1200/JCO.23.00619. Epub 2023 Jun 6.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Flow Cytometry
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
  • Neoplasm, Residual
  • Patients
  • Treatment Outcome